biotech / news / / scanx.trade
Q-Line Biotech released the subscription details for its initial public offering (IPO) Total subscription level reached 4.09 times the available shares.
Q-Line Biotech's IPO was oversubscribed 4.09 times overall across all investor categories.
KEY POINTS
- Non-Institutional Buyers (bHNI) subscribed 5.84 times their allocated shares, showing highest enthusiasm.
- Qualified Institutional Buyers (QIBs) subscribed 4.15 times, while retail investors subscribed 3.56 times.
- The Employee category showed no subscription, recording zero demand for the IPO allocation.
COMPANIES
Summarized by Newsio from scanx.trade. How we summarize →